Clinical Trial: Treatment of Mild to Moderate Joint Pain in Patients With Chronic Plaque Psoriasis Receiving Efalizumab
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Phase 4 Study to Assess the Practical Management of Mild to Moderate Arthritic or Arthralgic Events in Patients With Chronic Plaque Psoriasis Receiving Efalizumab
Brief Summary: The purpose of this study is to evaluate tolerability and effectiveness of conventional treatment for mild to moderate arthritic or arthralgic symptoms while subjects are being treated with efalizumab for psoriasis.
Detailed Summary: The study objective is to demonstrate that mild to moderate arthritis or arthralgia may be controlled using conventional therapy while being treated with efalizumab, without loss of efficacy.
Sponsor: Probity Medical Research
Current Primary Outcome:
Original Primary Outcome: The percentage of episodes of mild to moderate arthritis or arthralgia successfully treated while continuing treatment with efalizumab. [ Time Frame: 8 weeks ]
Current Secondary Outcome: The proportion of subjects who sustain or improve their psoriasis in response to efalizumab. [ Time Frame: 8 weeks ]
Original Secondary Outcome: Same as current
Information By: Probity Medical Research
Dates:
Date Received: August 1, 2007
Date Started: July 2007
Date Completion:
Last Updated: April 8, 2009
Last Verified: April 2009